Clinical Trials Logo

Vitamin D Supplement clinical trials

View clinical trials related to Vitamin D Supplement.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05649462 Completed - Ulcerative Colitis Clinical Trials

Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative Colitis

Start date: January 1, 2020
Phase:
Study type: Observational

It is uncertain whether vitD3 supplementation is beneficial for the remission of ulcerative colitis (UC). The effects of vitD3 supplements on the efficacy of vidrecizumab in Chinese UC patients were retrospectively analyzed. Methods: Patients with moderate to severe UC were recorded. These patients were initially treated with VDZ. VitD3 supplementation was defined as 400IU/d vitD3 supplementation during the first infusion of VDZ and continued throughout the follow-up period. Disease activity was assessed using the modified Mayo score.

NCT ID: NCT04606017 Completed - Crohn Disease Clinical Trials

Effect of Vitamin D Supplementation on Infliximab Response in Patients With Crohn's Disease

Start date: January 1, 2014
Phase:
Study type: Observational

Background: It remains uncertain whether vitD3 supplementation is beneficial for remission of Crohn's disease (CD). The influence of vitD3 supplementation on Infliximab (IFX) efficacy was retrospectively analyzed in Chinese CD patients. Methods: Patients with moderate-to-severe CD, who were bio-naïve and prescribed with IFX treatment for at least 54 weeks were recorded. VitD3 supplementation was defined as patients additionally took oral vitD3 (125 IU/d) within 3 days after the first infusion and persisted in the whole follow-up period. Disease activity was assessed using Harvey-Bradshaw Index (HBI). Serum cytokine profiles were quantitatively analyzed in a subset of all patients at baseline and 54-week after intervention.

NCT ID: NCT04276649 Completed - Ulcerative Colitis Clinical Trials

A Retrospective Analysis: the Influence of Caltrate Supplement on the Effect of Mesalazine in Ulcerative Colitis

Start date: January 1, 2015
Phase:
Study type: Observational

Aims:Retrospectively observe the effects of Caltrate supplementation on the clinical effect of mesalazine in patients with ulcerative colitis. Design: From January 2015 to December 2020, through retrieving the clinical database of the Second Affiliated Hospital of Wenzhou Medical University, patients with active UC who accepted mesalazine treatment were enrolled. According to whether Caltrate was supplemented at the same time, the patients were divided into supplementary group and non-supplementary group. The modified Mayo score and several laboratory indicators were compared between the two groups.